IMI impact on diabetes - Event

Start Date 08/06/2021 End Date 08/06/2021
Online, Virtual Event

About this event

IMI has a strong diabetes project portfolio, covering T1,  T2 and diabetes complications, with several projects addressing different aspects of those diseases. Some are studying the underlying causes of the disease and the internal processes that lead to the destruction of the cells in the pancreas that produce insulin, in order to develop treatments. Others aim to detect clues as to how the disease will progress in different patients. Finally, many projects focus on detecting, preventing and treating the complications associated with diabetes.

 

This event is part of  a series of  live sessions that IMI is organising on IMI Impacts, where key actors will explore the key challenges in their respective fields and demonstrate how IMI contributed. During these sessions, we will also share patients’ testimonies, as they are the ultimate beneficiaries of IMI’s funded research.


Furthermore, we hope to engage IMI stakeholders in a broader discussion on IMI’s impact and ask them for their active participation in these live events. With this initiative, we aim to demonstrate the successful IMI model of radical collaboration.

 

Therefore, we invite you to register via the link below! 

 

For more information on about IMI Impact on diabetes go here! 

 

Registration

 

Click here to register

Registration for this event is free but obligatory.

 

For any questions about this event please contact Rui Ribeiro at imi_events@imi.europa.eu.

 

Draft agenda

 

15:00-15:10

Welcome and introduction

by Magda Gunn, Scientific Project Manager, IMI

15:10-15:40

Life with diabetes - patient testimonies 

by 

Veerle Vanhuyse, Communication Representative, INNODIA
Ken Tait, International diabetes advocate

15:40-16:10

Highlights from IMI diabetes portfolio – paving the way for precision medicine and disease modifying therapies

by

Chantal Mathieu, Chair Endocrinology, University of Leuven

Leif Groop, Lund University

16:10-16:50

Q&A Time

 

16:50-17:00

Closing remarks

by Magda Gunn, Scientific Project Manager, IMI

 

Meet the speakers

 

Speaker pic_Veerle Vanhuyse Speaker pic_Ken Tait Speaker pic_Chantal Mathieu Speaker pic_Leif Groop

Veerle Vanhuyse

Communication Representative

Ken Tait

International diabetes advocate

Chantal Mathieu

Chair Endocrinology

University of Leuven  

 

Leif Groop

Lund University

 

 

Moderated by:

Speaker pic_Magda Gunn

Magda Gunn

Scientific Project Manager, IMI